Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1

Ryoichi Takayanagi, Wei Liu, Takeshi Ito, Keizo Ohnaka, Hajime Nawata

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Big endothelin-1 (big ET-1) is converted into an active form, ET-1, by endothelin-converting enzyme-1 (ECE-1). To assess the mechanism of substrate recognition by ECE-1, we examined the effects of variously substituted analogues of big ET-1 on ECE-1 activity, using solubilized membranes prepared from human ECE-1-expressed CHO-K1 cells. Among the big ET-1 analogues tested, [21Phe]big ET-1[18-34] and [31Ala]big ET-1[18-34] exhibited significant inhibition of ECE-1. A kinetic analysis revealed [21Phe]big ET-1[18-34] to be a competitive inhibitor (Ki = 21 μM) and [31Ala]big ET-1[18-34] to be a noncompetitive inhibitor (Ki = 36 μM). These results suggested that ECE-1 recognizes big ET-1 at the P1 position and the C-terminal region in a different manner and that modification of these regions can produce ECE-1 inhibitors.

Original languageEnglish
Pages (from-to)S62-S63
JournalJournal of Cardiovascular Pharmacology
Issue numberSUPPL. 1
Publication statusPublished - 1998

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1'. Together they form a unique fingerprint.

Cite this